Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with inflammatory bowel disease (IBD) — either ulcerative colitis or Crohn's disease — and are currently being treated with a type of medication called TNF inhibitors (medicines that reduce inflammation by blocking a specific protein in the body).
- People who also have a condition affecting the spine and joints called axial spondyloarthropathy (axial SpA), confirmed by meeting specific clinical signs such as low back pain lasting 3 months or more that feels better with movement but not with rest, reduced movement in the lower back, and reduced ability to expand the chest.
- People whose imaging (such as X-rays or scans) shows a specific pattern of inflammation in the joints at the base of the spine (sacroiliitis), at a level confirmed by the trial site.
- People whose IBD diagnosis has been confirmed and whose disease activity has been measured using standard tests, including blood tests, stool tests, and procedures such as endoscopy and tissue sampling, as well as disease activity scoring tools (Mayo score for ulcerative colitis or the Crohn's Disease Activity Index).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have other autoimmune diseases, diabetes, liver cirrhosis or failure, chronic kidney failure, or any form of cancer (malignancy).
- People whose back pain is caused by mechanical (physical/structural) reasons rather than inflammation, or who have conditions such as fractures, slippage of the spine bones (spondylolisthesis), tumours of the spine, or kidney stones.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Salwa salaheldin elgendi, professor doctor, Assiut University
Phone: +20 115 608 3878
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
prevalence of SPA in IBD patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.